A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck

By Hadden J.   Verastegui E.   Barrera J.L.   Kurman M.   Meneses A.   Zinser J.W.   de la Garza J.   Hadden E.  

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1073-1081

Elsevier

Access to resources Recommend Favorite

Management of lymph node metastases from an unknown primary site to the head and neck (Review)

By        

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 917-922

Spandidos Publications

Access to resources Recommend Favorite

COX-2, Cell Proliferation and PMA in Head-and-Neck Cancer Cells

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 9, Iss. 4, 2009-12 ,pp. : 203-218

Bentham Science Publishers

Access to resources Recommend Favorite

Sentinel lymph node biopsy in cervical cancer: A metaanalysis

By        

Molecular and Clinical Oncology, Vol. 1, Iss. 6, 2013-01 ,pp. : 1025-1030

Spandidos Publications

Access to resources Recommend Favorite

Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II/III N1, 2 esophageal cancer

By                          

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 719-724

Spandidos Publications

Access to resources Recommend Favorite